McCarthy Sean A. 4
4 · CytomX Therapeutics, Inc. · Filed Mar 21, 2024
Insider Transaction Report
Form 4
McCarthy Sean A.
DirectorCEO
Transactions
- Sale
Common Stock
2024-03-19$2.09/sh−20,223$42,175→ 524,481 total
Holdings
- 93,158(indirect: See footnote)
Common Stock
Footnotes (3)
- [F1]The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of restricted stock units.
- [F2]Includes 197,500 restricted stock units.
- [F3]Shares held by Sean A. McCarthy 2018 Trust, of which Reporting Person is trustee.